Nicholas Schaum
Senior Research Associate at the University of Cambridge, co-founder at Covalent.Bio
My goal is to keep people as healthy as possible for as long as possible by targeting the biological mechanisms of aging, as aging is by far the largest risk factor for diseases like cancer, heart disease, Alzheimer's, stroke, and diabetes. I have largely focused on generating foundational, public-good datasets characterizing aging and the effects of aging interventions across diverse organs and cell types. Ultimately, I hope to raise all boats and accelerate the design of therapies to prevent or reverse the damages of aging.
As a graduate student and postdoc, I was fortunate enough to help lead one of the largest single-cell RNA-seq efforts in this area: Tabula Muris Senis. More recently I was given the tremendous opportunity to help start Rejuvenome, an even bigger effort to catalog the effects of aging interventions by combining organism-wide multi-omics with a variety of longitudinal functional assays. Although that ended prematurely, I am now helping to start something similar at the United Kingdom Research and Innovation Medical Research Council National Mouse Genetics Network's new Ageing Cluster.
Visit website: https://www.stemcells.cam.ac.uk/staff/nicholas-schaum
See alsoDetails last updated 27-Jul-2025
Nicholas Schaum is also referenced in the following:
74th Annual Scientific Meeting of the BSRA (2025)
03-Sep-2025
A compelling lineup of speakers from all areas of the biology of ageing (Manchester, UK)